Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment
Study Type
OBSERVATIONAL
Enrollment
3,114
Patients under daily life treatment receiving Pritor according to local drug information.
Unnamed facility
Many Locations, Romania
Unnamed facility
Many Location, Slovakia
To evaluate efficacy and safety of telmisartan in patients with arterial hypertension, who do not tolerate ACEI treatment
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.